16 Bit's mission is to create trusted AI Software-as-a-medical device to improve the quality, efficiency, and accessibility of healthcare for all people.

20/20 OptimEyes Technologies is a spin out from the Sheardown Lab at McMaster University. We are committed to improving treatments for patients suffering from vision loss and other ocular conditions. Led by a talented team and experienced key ...

A.I. VALI analyzes physicians' voices during procedures in real-time using Machine Learning (ML) and Deep Learning (DL) techniques, as well as data obtained from medical imaging such as endoscopy video footage and tissue biopsy specimens. The AI is modular. AIDREA(TM) is a global platform that provides clients with accurate, reproducible, and inexpensive real-time analysis. AIDREA(TM) has a significant impact on the quality of analysis in the early diagnosis of diseases such as cancer, allowing for the most tailored treatment approach.

Able Innovations is developing advanced medical devices to tackle the pressing problem of patient transfer in healthcare. Their technology is revolutionizing the quality of care provision - providing a safe, efficient, and dignified care experience for patients and caregivers.

Advanced Chemistry Development, Inc., (ACD/Labs) develops and commercialzes informatics solutions for chemical, biochemical, and pharmaceutical R&D.

AceAge is a healthcare technology company, creating intuitive products to ease the aging process and improve health outcomes. AceAge is the company behind the next innovation in healthcare technology. Its upcoming product is a home health appliance designed to help people take their medication properly. Karie is a personal health companion that organizes, schedules, and dispenses pills with easy one-button control. The CEO of AceAge, Spencer Waugh, created Karie to increase the health and safety of medical patients, and as a way to minimize the negative consequences of missed medications or general failure to adhere to medication directions. The success of medicine is dependent on the patient’s compliance with the medical directions that accompany it, making it an integral part of healthcare. The total direct and indirect costs of nonadherence in the US annually is $290 billion. By making daily medicine routines completely automated, Karie removes the chance of human error. Karie uses common multi-dose pouch packaging that can be pre-set by pharmacists. Doses are scheduled, delivered and monitored for the user. Karie is easy to use, enables greater patient autonomy and ensures better healthcare through a highly coordinated program.

Acorn Biolabs is a healthcare technology company that provides access to the future of cell-based medicine through a non-invasive, follicle-based cell collection and cryopreservation service. Acorn Biolabs is cryopreserving people's healthy young cells for use in future regenerative treatments. Acorn Biolabs' services are available to consumers directly through at-home and in-clinic collections and are available across Canada through a network of clinic and pharmacy partners.

AiimSense specializes in the development of portable brain scanners, leveraging electromagnetic brain imaging technology to innovate in the field of stroke diagnosis and monitoring. By transforming traditional, expensive head scan procedures into real-time, bedside accessible solutions, AiimSense aims to significantly improve patient outcomes. The company's technology enables early diagnosis of stroke with a system that is more cost-effective and accessible than traditional MRI, making it a valuable tool in medical settings for timely intervention. AiimSense's commitment to changing the stroke management paradigm is evident in its active participation in medical technology events and its pursuit of collaborative efforts to bring its lifesaving invention to the medical world.

Allarta is an early stage life science technology company. Subscribe below to hear updates about our work.

AmacaThera is a clinical-stage biotechnology company developing a novel drug delivery platform to improve patient outcomes across multiple therapeutic areas, including post‑surgical pain management, cancer, and other hard‑to‑reach target areas. AmacaThera is developing combination products at the interface of biomaterials and pharmaceuticals.

Arrayus Technologies is a fast-growing medical technology company that is ushering in a new era of non-invasive cancer therapy.

Aspect Biosystems is a Canadian biotechnology company creating bioprinted tissue therapeutics to transform how we treat disease. Our bold team of innovators and entrepreneurs have joined us from all over the globe to create a new class of regenerative medicine and work towards a future where our bioprinted tissues are used to save lives and make people healthier. We are endlessly curious and wildly passionate about what we do. Every person on our team is a key contributor to our success and is eager to roll up their sleeves to make a difference in the ever-changing world of biotech. If you are committed to making a real impact and accelerating the development of life-changing therapies, we want to hear from you! At Aspect Biosystems, we celebrate diversity and are committed to creating an inclusive environment for all employees. All aspects of employment including the decision to hire, promote, discipline, or terminate, will be based on merit, competence, performance, and business needs. We do not discriminate on the basis of race, colour, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, provincial, or local law.